These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 6116000)

  • 1. Antihypertensive effect of the new oral angiotensin converting enzyme inhibitor "MK-421".
    Gavras H; Biollaz J; Waeber B; Brunner HR; Gavras I; Davies RO
    Lancet; 1981 Sep; 2(8246):543-7. PubMed ID: 6116000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the new oral angiotensin converting enzyme inhibitor MK-421 in human hypertension.
    Gavras H; Biollaz J; Waeber B; Brunner HR; Gavras I; Davies RO
    Clin Exp Hypertens A; 1982; 4(1-2):303-14. PubMed ID: 6280900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade.
    Biollaz J; Brunner HR; Gavras I; Waeber B; Gavras H
    J Cardiovasc Pharmacol; 1982; 4(6):966-72. PubMed ID: 6185790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enalapril in treatment of hypertension with renal artery stenosis. Changes in blood pressure, renin, angiotensin I and II, renal function, and body composition.
    Hodsman GP; Brown JJ; Cumming AM; Davies DL; East BW; Lever AF; Morton JJ; Murray GD; Robertson JI
    Am J Med; 1984 Aug; 77(2A):52-60. PubMed ID: 6089557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The acute effects of the new angiotensin I-converting enzyme inhibitor, enalapril maleate, on blood pressure, plasma renin, aldosterone and kinins in hypertensive patients].
    Gotoh M; Mizuno K; Hashimoto S; Kunii N; Fukuchi S
    Nihon Naibunpi Gakkai Zasshi; 1985 May; 61(5):619-29. PubMed ID: 2991035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK-421) in essential hypertension.
    Jackson B; Cubela R; Johnston CI
    J Hypertens; 1984 Aug; 2(4):371-7. PubMed ID: 6099390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the oral angiotensin-converting enzyme inhibitor MK-421 in human hypertension.
    Gavras H; Biollaz J; Waeber B; Brunner HR; Gavras I; Sackel H; Charocopos F; Davies RO
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():281s-283s. PubMed ID: 6274572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
    Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral and renal effects of MK-421 (enalapril) in hypertensive subjects.
    de Leeuw PW; Hoogma RP; van Soest GA; Tchang PT; Birkenhäger WH
    J Cardiovasc Pharmacol; 1983; 5(5):731-6. PubMed ID: 6195458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report.
    Karlberg BE; Fyhrquist F; Grönhagen-Riska C; Tikkanen I; Ohman KP
    Scand J Urol Nephrol Suppl; 1984; 79():103-6. PubMed ID: 6089307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of enalapril, a new converting enzyme inhibitor, in hypertension.
    Ferguson RK; Vlasses PH; Swanson BN; Mojaverian P; Hichens M; Irvin JD; Huber PB
    Clin Pharmacol Ther; 1982 Jul; 32(1):48-53. PubMed ID: 6282527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enalapril and atenolol in primary hypertension--a comparative study of blood pressure lowering and hormonal effects.
    Ohman KP; Karlberg BE
    Scand J Urol Nephrol Suppl; 1984; 79():93-7. PubMed ID: 6089325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of blood pressure and angiotensin responses to the renin inhibitor Ro 42-5892 and the angiotensin converting enzyme inhibitor enalapril in essential hypertension.
    van den Meiracker AH; Admiraal PJ; Derkx FH; Kleinbloesem C; Man in 't Veld AJ; van Brummelen P; Mulder P; Schalekamp MA
    J Hypertens; 1993 Aug; 11(8):831-8. PubMed ID: 8228207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic and antihypertensive effects of the new oral angiotensin-converting-enzyme inhibitor MK-421 (enalapril).
    Fouad FM; Tarazi RC; Bravo EL; Textor SC
    Hypertension; 1984; 6(2 Pt 1):167-74. PubMed ID: 6327515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of eprosartan versus enalapril in hypertensive patients on the renin-angiotensin-aldosterone system and safety parameters: results from a 26-week, double-blind, multicentre study. Eprosartan Multinational Study Group.
    Gavras I; Gavras H
    Curr Med Res Opin; 1999; 15(1):15-24. PubMed ID: 10216807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive efficacy of once daily MK-521, a new nonsulfhydryl angiotensin-converting enzyme inhibitor.
    Rotmensch HH; Vlasses PH; Swanson BN; Irvin JD; Harris KE; Merrill DG; Ferguson RK
    Am J Cardiol; 1984 Jan; 53(1):116-9. PubMed ID: 6318543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a new angiotensin-converting enzyme inhibitor, MK 421, in normal men and patients.
    Kono T; Oseko F; Ikeda F; Nakano R; Taniguchi A; Imura H; Endo J
    Endocrinol Jpn; 1982 Oct; 29(5):615-22. PubMed ID: 6303766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK421): evidence for role of renin system in normotensive subjects.
    MacGregor GA; Markandu ND; Bayliss J; Roulston JE; Squires M; Morton JJ
    Br Med J (Clin Res Ed); 1981 Aug; 283(6288):401-3. PubMed ID: 6266576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative pilot study of enalapril, a new converting enzyme inhibitor, and hydrochlorothiazide in essential hypertension.
    Ferguson RK; Vlasses PH; Irvin JD; Swanson BN; Lee RB
    J Clin Pharmacol; 1982 Jul; 22(7):281-9. PubMed ID: 6286734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
    Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A
    Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.